Back to Browse Journals » Vascular Health and Risk Management » Volume 4 » Issue 2

Risk factors for vascular dementia: Hypotension as a key point

Authors Rita Moretti, Paola Torre, Rodolfo M Antonello, Davide Manganaro, Cristina Vilotti, Gilberto Pizzolato

Published 11 April 2008 Volume 2008:4(2) Pages 395—402


Rita Moretti, Paola Torre, Rodolfo M Antonello, Davide Manganaro, Cristina Vilotti, Gilberto Pizzolato

Department of Internal Medicine and Clinical Neurology University of Trieste, Italy

Abstract: Physiologically, the cerebral autoregulation system allows maintenance of constant cerebral blood flow over a wide range of blood pressure. In old people, there is a progressive reshape of cerebral autoregulation from a sigmoid curve to a straight line. This implies that any abrupt change in blood pressure will result in a rapid and significant change in cerebral blood flow. Hypertension has often been observed to be a risk factor for vascular dementia (VaD) and sometimes for Alzheimer disease although not always. Indeed, high blood pressure may accelerate cerebral white matter lesions, but white matter lesions have been found to be facilitated by excessive fall in blood pressure, including orthostatic dysregulation and postprandial hypotension. Many recent studies observed among other data, that there was a correlation between systolic pressure reduction and cognitive decline in women, which was not accounted for by other factors. Baseline blood pressure level was not significantly related to cognitive decline with initial good cognition. Some researchers speculate that blood pressure reduction might be an early change of the dementing process. The most confounding factor is that low pressure by itself might be a predictor of death; nevertheless, the effect of low blood pressure on cognition is underestimated because of a survival bias. Another explanation is that clinically unrecognized vascular lesions in the brain or atherosclerosis are responsible for both cognitive decline and blood pressure reduction. We discuss the entire process, and try to define a possible mechanism that is able to explain the dynamic by which hypotension might be related to dementia.

Keywords: vascular dementia, hypotension, low blood pressure, alzheimer disease

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF] 


Other article by this author:

Depression in vascular pathologies: the neurologist's point of view

Moretti R, Bernobich E, Esposito F, Torre P, Antonello RM, De Angelis L, Bellini G

Vascular Health and Risk Management 2011, 7:433-443

Published Date: 12 July 2011

Readers of this article also read:

Enhanced local bioavailability of single or compound drugs delivery to the inner ear through application of PLGA nanoparticles via round window administration

Cai H, Wen X, Wen L, Tirelli N, Zhang X, Zhang Y, Su H, Yang F, Chen G

International Journal of Nanomedicine 2014, 9:5591-5601

Published Date: 1 December 2014

The effect of intravitreal bevacizumab and ranibizumab on cutaneous tensile strength during wound healing

Christoforidis JB, Wang J, Jiang A, Willard J, Pratt C, Abdel-Rasoul M, Roy S, Powell HM

Clinical Ophthalmology 2013, 7:185-191

Published Date: 24 January 2013

Towards real-time detection of tumor margins using photothermal imaging of immune-targeted gold nanoparticles

Jakobsohn K, Motiei M, Sinvani M, Popovtzer R

International Journal of Nanomedicine 2012, 7:4707-4713

Published Date: 28 August 2012

Combination of valproate and paroxetine in mice exposed to picrotoxin

Kamal SM

International Journal of Nanomedicine 2012, 7:2583-2589

Published Date: 23 May 2012

Barriers to cardiovascular risk prevention and management in Germany – an analysis of the EURIKA study

Schmieder RE, Goebel M, Bramlage P

Vascular Health and Risk Management 2012, 8:177-186

Published Date: 15 March 2012

Levosimendan neither improves nor worsens mortality in patients with cardiogenic shock due to ST-elevation myocardial infarction

Elmir Omerovic, Truls Råmunddal, Per Albertsson, et al

Vascular Health and Risk Management 2010, 6:657-663

Published Date: 26 August 2010

Silent cerebral infarction in chronic heart failure: Ischemic and nonischemic dilated cardiomyopathy

Guliz Kozdag, Ercument Ciftci, Dilek Ural, Tayfun Sahin, Macit Selekler, et al

Vascular Health and Risk Management 2008, 4:463-469

Published Date: 11 April 2008